GleamWall
中文EN

ACON Aclarion, Inc.

Services-Medical Laboratories · Nasdaq · SEC CIK 1635077 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY46.0%
TTM net income YoY-37.9%
TTM EPS YoY99.7%
Revenue 3-yr CAGR5.4%
Net income 3-yr CAGR—

Margins

Gross margin29.1%
Operating margin-10,789.2%
Net margin-10,260.0%
FCF margin—
EBITDA margin-10,662.3%

Returns

ROE-74.1%
ROA-69.7%
ROIC (approx.)-958.9%
Asset turnover0.01x

Leverage & solvency

Liabilities / assets6.5%
Debt / equity0.00x
Current ratio14.17x
Interest coverage—

Cash quality & payout

Operating cash flow / net income0.88x
Accruals ratio-8.0%
Payout ratio—
Capex / revenue—

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31
Income statement
Revenue$75,730$45,724
Cost of revenue$68,902$84,658
Gross profit$6,828-$38,934
R&D expense$1.03M$888,766
SG&A expense$4.12M$3.61M
Operating income-$7.05M-$5.51M
Interest expense—$64,084
Pretax income-$7.23M-$6.99M
Income tax$0$0
Net income-$7.23M-$6.99M
EBITDA-$6.82M-$5.32M
EPS (basic)-13.61-7,478.90
EPS (diluted)-13.61-7,478.90
Weighted avg. shares (diluted)532,036943
Banking
Deposits—$463,661
Balance sheet
Cash & equivalents$12.02M$463,661
Receivables$29,680$18,326
Current assets$12.40M$824,279
PP&E, net$24,169$5,499
Intangibles$1.25M$1.29M
Total assets$13.67M$2.12M
Current liabilities$837,287$1.15M
Total liabilities$837,287$1.15M
Shareholders' equity$12.84M$970,057
Shares outstanding854,3711,370
Cash flow statement
Operating cash flow-$7.16M-$5.27M
Capital expenditure$21,528$5,115
Free cash flow-$7.19M-$5.28M
Investing cash flow-$203,902-$321,937
Financing cash flow$18.95M$5.03M
Depreciation & amortization$227,406$193,139
Stock-based compensation$105,368$287,455

Free plan shows the latest 2 periods; Pro shows all 5 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.